Alzheimer's disease brain extract stimulates the survival of cerebral cortical neurons from neonatal rats

Alzheimer's disease brain extract stimulates the survival of cerebral cortical neurons from neonatal rats

BIOCHEMICAL Vol. 150, No. 3, 1988 February 15, 1988 ALZHEIMER'S DISEASE BRAIN EXTRACT STIMULATES CEREBRAL CORTICAL Yoko Uchida' , Yasuo AND BI...

1MB Sizes 2 Downloads 42 Views

BIOCHEMICAL

Vol. 150, No. 3, 1988 February 15, 1988

ALZHEIMER'S

DISEASE

BRAIN

EXTRACT STIMULATES

CEREBRAL CORTICAL Yoko Uchida'

, Yasuo

AND BIOPHYSICAL RESEARCH COMMUNICATIONS Pages 1263-1267

THE SURVIVAL

OF

NEURONS FROM NEONATAL RATS Ihara'

and Masanori

Tomonaga3

Department of 'Clinical Pathology and 2Physiology, Tokyo Metropolitan Institute of Gerontology, 35-2 Sakaecho, Itabashiku, Tokyo 173, Japan 3Department of Neuropathology, Faculty of Medicine, University Tokyo Received

December

21,

Institute of Tokyo, 113, Japan

of

Brain Research, Hongo, Bunkyoku,

7-3-l

1987

Cell cultures of neonatal rat cerebral cortex in a serum-free medium were used to investigate a lack of neuronotrophic factors A few neurons survived in the in Alzheimer's disease (AD) brain. The addition of normal brain extract absence of brain extract. AD brain resulted in a 2.5-fold increase in neuronal survival. extract contained 4-fold neuronotrophic activity of normal brain extract. These findings are in contrary to the previous hypotheThese new sis of a lacking neuronotrophic factors in AD brain. results may change the concept of mechanism of neuronal death in AD. 0 1988Academic Press, Inc.

Severe

loss

patients

with

caused

by either

creased

of

AD patients cortical

is observed

Alzheimer's a lack

responsiveness

To investigate lacking

neurons

the

in AD brain, examined

disease

in

(AD);

this

of neuronotrophic of

neurons

possibility

to

that

neuronotrophic in primary

the

cerebral cell

factors neuronotrophic

culture

loss

might

be

(1)

or de-

factors

of brain of rat

of

factors

neuronotrophic effect

cortex

(2). are

extracts

neonatal

from

cerebral

neurons.

Abbreviation: AD, Alzheimer's disease; tangle; MEM, Eagle's minimal essential associated protein 2; PNS, peripheral central nervous system

NFT, neurofibrillary medium; MAP2, microtubule nervous system; CNS, 0006-291X/88

1263

$1.50

Copyright 0 1988 by Aca&mic Press, Inc. All rights of reproduction in any form reserved.

Vol. 150, No. 3, 1988

BIOCHEMICAL

AND BIOPHYSICAL RESEARCH COMMUNICATIONS

MATERIALS

AND METHODS

Preparation of human brain extracts: Human brain (frontal or parietal cortex) was homogenized with water and centrifuged at 20,000 x g. The insoluble residue was homogenized with 2% SDS-50mM tris HCl (pH 7.6) and centrifuged again. The residue was stained with Congo red and used to determine whether brain tissue contained large amounts of neurofibrillary tangle (NFT) or senile plaque core. Brains from ten nondemented subjects (61-91 years of age), which did not have such changes, were used as Brains from six patients (61-85 years of age) normal controls. with clinically and neuropathologically defined AD, which had abundant NFT, were used as AD. Cell culture: Cerebral cortex was dissected from rats 0 days of age, dissociated with 0.08% trypsin-0.008% DNase 1 at 37OC for 20 min, and passed through 62 urn nylon mesh. The cells (5~10~ cells /well) were seeded on glass multiwell plates (9x9 mm) precoated and fed in MEM-N2(4) containing with gelatin-polyornithine(3), ImM pyruvate in the absence or presence of human brain extracts (0.25 mg of protein/ml) for 3 days (37OC, 5%CO -air). Cultured cells were fixed with 4% paraformaldehyde and 6 0% methanol/5% acetic acid, and stained with an monoclonal antibody to the neuron-specific microtubule associated protein (MAP) 2 (Amersham) by the Avidin-Biotin Complex method. The total number of MAP2 positive cells was counted under a light microscope.

RESULTS Fig.1

shows neonatal

chemically About

defined

70% of

presence

60% of

of either

surviving

results

enhanced

about

nondemented stics

brain

control

of AD (Fig.2

neuronotrophic

human

were

labeled

with

of brain

either

brain

in

extracts.

antibody In

extract.

control

the

to the

or AD patients,

cells

were in

increased.

the

shown in

Fig.2.

In

this

cortical

neurons

survived

presence

low-density in

the

(Fig.2

left).

Neuronal

survival

was

by the

addition

of brain

extracts

from

patients middle).

activity

or without

grown

were MAP2 positive

are

extract 2.5-fold

neurons

and unlabeled

a few cerebral

culture, of

from

cells

The numerical

cortical

absence

MAPZ-labeled

extracts.

absence

the

extracts

brain

cell

cells

MAP2 in

of both

with

surviving

of brain

numbers About

medium

the

neuron-specific

cerebral

without

any pathological

As shown in in

brain

extracts 1264

Fig.2 from

right,

characterithe

AD patients

was

BIOCHEMICAL

Vol. 150, No. 3, 1988

Fig.1

MAPZ-stained

cells

AND BIOPHYSICAL RESEARCH COMMUNICATIONS

cultured

in the absence of brain

extract

(CON) or Alzheimer's

disease

(NON), or presence of control (AD) brain

extracts.

15

10

5

0

.I3 NON

Fig.2

The effects

of brain

six Alzheimer's natal

rat

specific

AD

CON

extracts

from ten control

disease (AD) patients

cerebral

cortical

MAP2 staining.

the presence of brain mean + SEM of three

on survival

neurons identified NONindicates

extract.

independent 1265

(CON) and of neo-

by neuron-

the culture

without

Each value represents determinations.

the

Vol. 150, No. 3, 1988

significantly

BIOCHEMICAL

higher

extracts

(about

AND BIOPHYSICAL RESEARCH COMMUNICATIONS

I-fold)

than

in

control

brain

(PtO.01).

DISCUSSION The results

indicate

disease

contains

cerebral

cortical

against

the

might

lead

higher

hypothesis to the

findings

are

in

AD brain

(5,6).

the

to

it

level

Since

not

act

neuronotrophic

for

continues,

trophic

injured

in

plaques

are

weight These

repair

despite

AD brain

have

results,

of

therefore,

enhanced of neurons

In sprouting

plaques

Numerous

concentrated

that

sprouting

level

enhance

consequence,

contains

In

of higher

abnormal

which

death. 1266

of neurononeurite

is

neuropathological

in

immature

senile

to high-moleculargrowing

metabolism

dendrites

neuron

the

and lead

in

of our factors

of

increase

(9).

may be involved

may be exhausted,

(5)

may neuronal

fact,

level

of neuronotrophic

substances

higher

responses,

responses

neurons

brain

of neuronotrophic

neurites

may paradoxically

to excitotoxic

rat

As an explanation

the

is

stimulate

adult

circuits.

in

occur

AD brain

sprouting

antiserum

plaques.

high

in

Moreover,

is

may abnormally

sprouting.

senile

senile

in

AD brain

to

existence

with

which

responses

Accumulation

stained

suggested

formation

that

contrary,

and lesions

factors

of damaged

(6).

heavily

(5)

are

factors On the

responses

may lead

the

within

MAPS (8)

sprouting

in AD brain.

occurs

hallmark

that

factors. which

neuronotrophic

brain

for

Our results

AD brain.

to conclude

substances,

sprouting

brain

of

in AD brain,

simply

loss

the

rat

activity

in

sprouting

in

reasonable

of Alzheimer's

rat.

of

neurons with

of neuronotrophic

factors

neonatal

a lack

consistent

those

is

from

of

cortex

of neuronotrophic

that

loss

accumulation

(7),

cerebral

level

neurons

our

similar

that

in AD and neurite or the

vulnerability to neuronal

Vol. 150, No. 3, 1988

BIOCHEMICAL

AND BIOPHYSICAL RESEARCH COMMUNICATIONS

ACKNOWLEDGMENTS

We are Clinical for

supply

grateful

to Dr.

Pathology,

Tokyo

of nondemented

Masahiro

Yoshimura,

Metropolitan human

Institute

Department of

of

Gerontology,

brains.

REFERENCES 1. 2. 3. 4. 5. 6. 7. 8. 9.

S.H. (1981) Ann. Neurol. 10, 499-505. Hefti, F. (1983) Ann. Neurol. 13, 109-110. Develop. Biol. 74, 136-151. Howrot, E. (1980) Bottenstein, J.E. and Sato, G.H. (1979) Proc. Natl. Acad. Sci. U.S.A. 76, 514-517. Geddes, J.W., Monaghan, D. T., Cotman, C.W., Lott, I.T., Kim, R.C. and Chui, H.C. (1985) Science 230, 1179-1181. Probst, A., Basler, V., Bron, B, and Ulrich, J. (1983) Brain Res. 268, 249-254. Yoshida, K., Kohsaka, S., Idei, T., Nii, S., Otani, M., Y. (1986) Neurosci. Lett. 66, 181-186. Toya, S. and Tsukada, Nukina, N. and Ihara, Y. (1983) Proc. Jap. Acad. 58 (B), 284292. Berhardt, R. and Matus, A. (1982) J. Cell Biol. 92, 589-593. AmelI

1267